Target intelligence / Profile preview

Basic helix–loop–helix transcription factor (bHLH)

Target
bHLH
Molecular classification
Transcription factor, DNA-binding protein, Dimerization protein, bHLH-PAS protein, bHLHZ (bHLH + leucine zipper)
01

Overview

The basic helix–loop–helix transcription factor is a class of dimeric transcriptional regulators defined by a protein motif with two α-helices separated by a loop, including a run of basic amino acids critical for DNA binding. Members of this family regulate gene transcription through binding to E-box DNA motifs, and they participate in the control of essential biological processes such as development, cell proliferation, tissue specification, metabolism, circadian rhythms, and stress responses. Functionality is often mediated via homo- or hetero-dimerization, and further specified by associated domains such as leucine-zippers (bHLHZ) or PAS domains (bHLH-PAS). While the family as a whole is not a specific drug target, individual bHLH proteins (e.g., c-Myc, HIF-1α, AHR, CLOCK) are key regulatory nodes and validated therapeutic targets implicated in various diseases, especially cancer and developmental disorders.

Other names
bHLH transcription factorhelix–loop–lix (HLH) proteinbasic HLH protein
02

Mechanism of action

(for drugs targeting individual bHLH proteins) - Inhibit DNA-binding activity - Disrupt dimerization - Block protein expression or stability - Modulate ligand-dependent activation

03

Biological functions

Regulation of gene expressionCell growth and proliferationCell differentiationTissue specificationNeurogenesisMyogenesisMuscle formationDevelopmental processesCircadian rhythm controlMetabolic regulationResponse to hypoxiaRegulation of immune function
04

Disease associations

CancerCardiovascular diseaseNeurodevelopmental disordersCircadian rhythm disordersImmune system disordersOther

Beyond the preview

Go deeper on Basic helix–loop–helix transcription factor (bHLH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Basic helix–loop–helix transcription factor (bHLH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call